AVAI
Atlas Venture Associates IX Portfolio holdings
AUM
$11.8M
This Quarter Return
-20.2%
1 Year Return
-58.35%
3 Year Return
-89.8%
5 Year Return
-87.69%
10 Year Return
–
AUM
$60.8M
AUM Growth
+$60.8M
(-35%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 88.34% |
| 2 | Technology | 7.75% |
| 3 | Communication Services | 3.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Intellia Therapeutics
NTLA
$1.22B
| $21.6M | 35.49% | 1,615,321 | – | – |
|
2
Spero Therapeutics
SPRO
$116M
| $14.6M | 24.02% | 1,376,968 | – | – |
|
|
SURF
3
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $6.6M | 10.86% | 4,645,453 | – | – |
|
4
Synlogic
SYBX
$17M
| $6.07M | 10% | 2,651,963 | – | – |
|
5
Cogent Biosciences
COGT
$1.69B
| $4.84M | 7.97% | 3,361,535 | – | – |
|
|
CBLK
6
DELISTED
Carbon Black, Inc. Common Stock
CBLK
| $4.71M | 7.75% | 181,273 | – | – |
|
7
Snap
SNAP
$12.1B
| $2.37M | 3.91% | 150,160 | – | – |
|